# Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects

> **NCT07679711** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 76 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Sitagliptin / Metformin hydrochloride extended-release tablet (Test)
- **DRUG:** Sitagliptin / Metformin hydrochloride extended-release tablet (Reference)

## Key facts

- **NCT ID:** NCT07679711
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-14
- **Primary completion:** 2023-03-22
- **Final completion:** 2023-03-22
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07679711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07679711, "Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07679711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*